| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |